PER 2.50% 8.2¢ percheron therapeutics limited

The FDA review for Sarepta is coming up next week, and I'm...

  1. 493 Posts.
    lightbulb Created with Sketch. 30
    The FDA review for Sarepta is coming up next week, and I'm curious if anyone has any insights that could impact the ANP study.

    It's possible that if the result is negative, there could be a pump-and-dump situation. Alternatively, the stock price could gradually decline before taking off.

    The choice is yours. Good luck!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.